Incyte

Incyte

Yahoo Finance • 2 days ago

Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story

NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Fly on Wall Street News Commentary - Wall Street's major indexes rallied together on Wednesday. As of 2:31 p.m. ET, the Dow Jones Industrial Average was up 1,552.12 points, or 3.0%, at 53,338.84, whil... Full story

Yahoo Finance • 12 days ago

Genmab, Incyte team up to develop experimental colorectal cancer treatment

[Incyte headquarters in Wilmington, Delaware, USA] JHVEPhoto/iStock Editorial via Getty Images Genmab (GMAB [https://seekingalpha.com/symbol/GMAB]) and Incyte (INCY [https://seekingalpha.com/symbol/INCY]) announced a clinical trial collab... Full story

Yahoo Finance • 13 days ago

Does Genmab Trial Deal Change The Bull Case For Incyte (INCY)?

Incyte and Genmab A/S announced a clinical trial collaboration to test INCB161734 with petosemtamab and standard chemotherapy in first line KRAS G12D mutated metastatic colorectal cancer, with Genmab running the Phase 1/2 study and Incyte... Full story

Yahoo Finance • 13 days ago

Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

Phase 1/2 study will evaluate petosemtamab plus INCB161734 and standard-of-care chemotherapy in first-line KRAS G12D-mutated metastatic colorectal cancer (mCRC) COPENHAGEN, Denmark & WILMINGTON, Del., October 24, 2026--(BUSINESS WIRE)--Ge... Full story

Yahoo Finance • 13 days ago

Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

Phase 1/2 study will evaluate INCB161734 plus petosemtamab and standard-of-care chemotherapy in first-line KRAS G12D-mutated metastatic colorectal cancer (mCRC) WILMINGTON, Del. & COPENHAGEN, Denmark, October 24, 2026--(BUSINESS WIRE)--In... Full story

Yahoo Finance • 14 days ago

How Halozyme, Up Nearly 90% This Year, Is Rivaling Merck And Hitting New Highs

Halozyme makes technologies that allow drugs delivered through intravenous infusion, or IV, to instead be given with under-the-skin shots Continue Reading... Full story

Yahoo Finance • 14 days ago

How Halozyme, Up 80% This Year, Is Rivaling Merck And Hitting New Highs

Halozyme makes technologies that allow drugs delivered through intravenous infusion, or IV, to instead be given with under-the-skin shots Continue Reading... Full story

Yahoo Finance • 17 days ago

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

Mestag Therapeutics -- Mr. Astley-Sparke brings more than two decades of biotech leadership, having scaled several highly innovative transatlantic companies, including Replimune, uniQure and BioVex -- Dr. Sandor brings more than 20 years... Full story

Yahoo Finance • 24 days ago

Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026

SAN DIEGO, Oct. 13, 2026 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology (IO), announced that Ming Wang (CEO) will participate in... Full story

Yahoo Finance • 26 days ago

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 29 days ago

Incyte to Report Third Quarter Financial Results

WILMINGTON, Del., October 08, 2026--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursday, October 29, 2026. The schedule f... Full story

Yahoo Finance • last month

Stock futures rise after Nasdaq hits record high

[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Stock index futures were higher on Tuesday, a day after the Nasdaq Composite touched a record high while investors looked ahead to trade data and comments from Federal Res... Full story

Yahoo Finance • last month

At a glance: stocks gapping up premarket

[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-up moves before the bell on Monday. Stock index futures came under immediate pressure on Monday after President Donald Trump rej... Full story

Yahoo Finance • 2 months ago

Specialised Therapeutics to commercialize Incyte’s Opzelura in Australia

[Partnership word near puzzle pieces. Teamwork concept. Strategic cooperation. Reliable partner. 3d render] Independent biopharmaceutical company Specialised Therapeutics announced an expansion of its partnership [https://seekingalpha.com... Full story

Yahoo Finance • 2 months ago

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: I... Full story

Yahoo Finance • 2 months ago

Robinhood Soars, SpaceX Orbits Entry: Five Stocks Near Buy Points

Robinhood stock surged in an end-of-week crypto rally. SpaceX is testing an aggressive entry. They lead five stocks near buy points. Continue Reading... Full story

Yahoo Finance • 2 months ago

INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?

Shares of Incyte INCY have rallied 23% year to date compared with the industry's growth of 5.2%. The stock has also outperformed the medical sector and the S&P 500 Index during this time frame. Much of this rally came after the company re... Full story

Yahoo Finance • 2 months ago

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical Affairs Experience MORRISTOWN, N.J., Sept. 10, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage onco... Full story

Yahoo Finance • 2 months ago

Stock futures mixed as traders look ahead to wholesale inflation report

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were mixed on Thursday as traders looked ahead to the wholesale inflation report. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) +0.1... Full story

Yahoo Finance • 2 months ago

Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks

In a recent interview on CNBC's Halftime Report, Josh Brown, CEO of Ritholtz Wealth Management, highlighted Incyte (NASDAQ: INCY) and Biogen (NASDAQ: BIIB) as two of his "Best Stocks in the Market." Brown said he wanted to focus on stocks... Full story